Singapore markets closed

Vir Biotechnology, Inc. (VIR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.62+0.03 (+0.31%)
At close: 04:00PM EST
9.61 -0.01 (-0.10%)
After hours: 07:18PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
427,211
1,580,472
1,087,068
67,245
711
Cost of revenue
30,178
146,319
65,865
-
-
Gross profit
397,033
1,434,153
1,021,203
-
-
Operating expenses
Research development
598,842
474,648
448,006
302,411
148,472
Selling general and administrative
175,796
161,762
160,793
70,937
37,598
Total operating expenses
711,128
601,085
600,452
364,225
178,690
Operating income or loss
-314,095
833,068
420,751
-296,980
-177,979
Total other income/expenses net
-30,449
-106,880
128,612
-4,467
-5,061
Income before tax
-274,717
754,280
549,802
-298,611
-174,529
Income tax expense
-12,695
238,443
21,218
54
154
Income from continuing operations
-262,022
515,837
528,584
-298,665
-174,683
Net income
-261,966
515,837
528,584
-298,665
-174,683
Net income available to common shareholders
-261,966
515,837
528,584
-298,665
-174,683
Basic EPS
-1.96
3.89
4.07
-2.51
-5.76
Diluted EPS
-1.96
3.83
3.96
-2.51
-5.76
Basic average shares
133,347
132,607
129,885
119,159
30,350
Diluted average shares
134,393
134,811
133,437
119,159
30,350